Simvastatin in combination with bergamottin potentiates TNF-induced apoptosis through modulation of NF-κB signalling pathway in human chronic myelogenous leukaemia

References

• Aggarwal BB. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 3:745–756.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB. 2004. Nuclear factor-kappaB: the enemy within. Cancer Cell. 6:203–208.
   PubMed Web of Science ®Google Scholar
• Ahmed T. 2013. High dose simvastatin as a potential anticancer therapy in leukemia patients [theses and dissertations] – Pharmacy, Paper 13. Available from: http://uknowledge.uky.edu/pharmacy_etds/13.
   Google Scholar
• Ahn KS, Aggarwal BB. 2005. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci. 1056:218–233.
   PubMed Web of Science ®Google Scholar
• Ahn KS, Sethi G, Aggarwal BB. 2007. Simvastatin potentiates TNF-alpha-induced apoptosis through the down-regulation of NF-kappaB-dependent antiapoptotic gene products: role of IkappaBalpha kinase and TGF-beta-activated kinase-1. J Immunol. 178:2507–2516.
   PubMed Web of Science ®Google Scholar
• Ahn KS, Sethi G, Aggarwal BB. 2008a. Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway. Biochem Pharmacol. 75:907–913.
   PubMed Web of Science ®Google Scholar
• Ahn KS, Sethi G, Chaturvedi MM, Aggarwal BB. 2008b. Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway. Int J Cancer. 123:1733–1740.
   PubMed Web of Science ®Google Scholar
• Bailey DG, Malcolm J, Arnold O, Spence JD. 1998. Grapefruit juice–drug interactions. Br J Clin Pharmacol. 46:101–110.
   PubMed Web of Science ®Google Scholar
• Chan KK, Oza AM, Siu LL. 2003. The statins as anticancer agents. Clin Cancer Res. 9:10–19.
   PubMed Web of Science ®Google Scholar
• Fraunberger P, Grone E, Grone HJ, Walli AK. 2009. Simvastatin reduces endotoxin-induced nuclear factor kappaB activation and mortality in guinea pigs despite lowering circulating low-density lipoprotein cholesterol. Shock. 32:159–163.
   PubMed Web of Science ®Google Scholar
• Gartel AL, Tyner AL. 2002. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther. 1:639–649.
   PubMed Web of Science ®Google Scholar
• Girennavar B, Jayaprakasha GK, Patil BS. 2007. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins. J Food Sci. 72:C417–C421.
   PubMed Web of Science ®Google Scholar
• Giri DK, Aggarwal BB. 1998. Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J Biol Chem. 273:14008–14014.
   PubMed Web of Science ®Google Scholar
• Haupt S, Berger M, Goldberg Z, Haupt Y. 2003. Apoptosis-the p53 network. J Cell Sci. 116:4077–4085.
   PubMed Web of Science ®Google Scholar
• He K, Iyer KR, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF. 1998. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol. 11:252–259.
   PubMed Web of Science ®Google Scholar
• Hwang YP, Yun HJ, Choi JH, Kang KW, Jeong HG. 2010. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression. Mol Nutr Food Res. 54:977–990.
   PubMed Web of Science ®Google Scholar
• John A, Tuszynski G. 2001. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res. 7:14–23.
   PubMedGoogle Scholar
• Kang S, Kim ES, Moon A. 2009. Simvastatin and lovastatin inhibit breast cell invasion induced by H-Ras. Oncol Rep. 21:1317–1322.
   PubMed Web of Science ®Google Scholar
• Le Goff-Klein N, Koffel JC, Jung L, Ubeaud G. 2003. In vitro inhibition of simvastatin metabolism, a HMG-CoA reductase inhibitor in human and rat liver by bergamottin, a component of grapefruit juice. Eur J Pharm Sci. 18:31–35.
   PubMed Web of Science ®Google Scholar
• Lilja JJ, Kivisto KT, Neuvonen PJ. 1998. Grapefruit juice–simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther. 64:477–483.
   PubMed Web of Science ®Google Scholar
• Manu KA, Shanmugam MK, Li F, Chen L, Siveen KS, Ahn KS, Kumar AP, Sethi G. 2013. Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products. J Mol Med (Berl). 92:267–276.
   Web of Science ®Google Scholar
• Matsushime H, Roussel MF, Ashmun RA, Sherr CJ. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell. 65:701–713.
   PubMed Web of Science ®Google Scholar
• Nguyen H, Gitig DM, Koff A. 1999. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome. Mol Cell Biol. 19:1190–1201.
   PubMed Web of Science ®Google Scholar
• Paine MF, Criss AB, Watkins PB. 2005. Two major grapefruit juice components differ in time to onset of intestinal CYP3A4 inhibition. J Pharmacol Exp Ther. 312:1151–1160.
   PubMed Web of Science ®Google Scholar
• Stewart ZA, Leach SD, Pietenpol JA. 1999. p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol Cell Biol. 19:205–215.
   PubMed Web of Science ®Google Scholar
• Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS, Jr.. 1998. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 281:1680–1683.
   PubMed Web of Science ®Google Scholar